UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SPCX
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.94% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5776
Lucid Diagnostics
LUCD
$153M
| $904K | ﹤0.01% |
845,314
+399,835
| +90% | +$431K |
|
5777
Thryv Holdings
THRY
$80.4M
| $904K | ﹤0.01% |
229,544
+74,855
| +48% | +$266K |
|
5778
ProShares Ultra Silver
AGQ
$1.51B
| $902K | ﹤0.01% |
13,266
+88
| +0.7% | +$9.7K |
|
5779
Lineage Cell Therapeutics
LCTX
$260M
| $900K | ﹤0.01% |
687,051
-683,410
| -50% | -$944K |
|
|
URG
5780
Ur-Energy
URG
$489M
| $899K | ﹤0.01% |
660,745
-445,035
| -40% | -$726K |
|
5781
Viemed Healthcare
VMD
$342M
| $897K | ﹤0.01% |
78,713
-139,095
| -64% | -$1.38M |
|
|
TUYA
5782
Tuya Inc
TUYA
$1.08B
| $894K | ﹤0.01% |
507,896
+276,136
| +119% | +$602K |
|
5783
CALL
Krystal Biotech
KRYS
$9.93B
| $892K | ﹤0.01% |
+2,400
| New | +$717K |
|
5784
Universal Logistics Holdings
ULH
$476M
| $890K | ﹤0.01% |
60,137
+5,924
| +11% | +$106K |
|
|
BCAR
5785
DELISTED
D. Boral ARC Acquisition I Corp
BCAR
| $887K | ﹤0.01% |
85,000
+84,426
| +14,708% | +$885K |
|
|
NMAX
5786
Newsmax Inc
NMAX
$1.32B
| $887K | ﹤0.01% |
107,070
-1,807
| -2% | -$13K |
|
5787
Bristow Group
VTOL
$1.23B
| $884K | ﹤0.01% |
21,393
+4,423
| +26% | +$198K |
|
5788
CALL
Truist Financial
TFC
$59.5B
| $882K | ﹤0.01% |
17,700
-17,600
| -50% | -$866K |
|
5789
PUT
CenterPoint Energy
CNP
$25.2B
| $881K | ﹤0.01% |
+20,000
| New | +$857K |
|
5790
enGene Therapeutics
ENGN
$129M
| $881K | ﹤0.01% |
509,087
+496,070
| +3,811% | +$2.02M |
|
5791
Dimensional Emerging Markets Value ETF
DFEV
$2.18B
| $879K | ﹤0.01% |
20,597
+390
| +2% | +$15.9K |
|
|
FRVO
5792
CALL
Fervo Energy
FRVO
$4.92B
| $877K | ﹤0.01% |
+30,000
| New | +$1.08M |
|
5793
Perion Network
PERI
$346M
| $874K | ﹤0.01% |
90,018
-1,021
| -1% | -$9.74K |
|
|
BBOT
5794
BridgeBio Oncology
BBOT
$386M
| $874K | ﹤0.01% |
114,655
+64,205
| +127% | +$536K |
|
5795
FerroAtlántica
GSM
$789M
| $873K | ﹤0.01% |
274,429
-63,348
| -19% | -$262K |
|
5796
Organogenesis Holdings
ORGO
$175M
| $872K | ﹤0.01% |
358,708
+151,180
| +73% | +$369K |
|
5797
Lennar Class B
LEN.B
$18.6B
| $871K | ﹤0.01% |
9,818
-6,041
| -38% | -$527K |
|
5798
Bowman Consulting
BWMN
$737M
| $871K | ﹤0.01% |
29,816
-9,828
| -25% | -$310K |
|
|
GOOD
5799
Gladstone Commercial Corp
GOOD
$612M
| $870K | ﹤0.01% |
70,743
-63,514
| -47% | -$791K |
|
5800
Xperi
XPER
$269M
| $869K | ﹤0.01% |
105,588
+52,476
| +99% | +$380K |
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.